This month we hear from our recent Past-President, Loralie Langman, who shares with us a few reflections about her time as President, her passion for the field and a few innovative technologies used in her place of practice, spanning clinical and forensic toxicology, TDM, and pharmacogenetics.

Loralie Langman
Director, Department of Laboratory Medicine and Pathology
Mayo Clinic, Rochester, MN, USA

This month we return to our interviews, and hear from Professor William Clarke, Chair of the TDM in Oncology committee. Alongside academic and clinical work, Professor Clarke is involved in an academic initiative in disposable microfluidic diagnostics, which has potential to impact the clinical application of TDM in resource limited settings.

William Clarke
Associate Professor, Pathology
Johns Hopkins School of Medicine, Baltimore, Maryland, USA

IATDMCT Blog: September Compass Highlight - A Personal Reflection from Professor Michael Oellerich

This month we bring to you a highlight from the IATDMCT September Compass. Professor Michael Oellerich is going to step down from his position of Editor-in-Chief of the Therapeutic Drug Monitoring journal.

We would like to acknowledge Professor Oellerich for his work and long record of success in leading the journal.

Personal Reflection
By Professor Michael Oellerich
Georg-August-University
Goettingen, Germany

16th IATDMCT Congress: Top Science Down Under
16-19 September 2018
Brisbane, QLD, Australia

Nineteen years on from the 6th IATDMCT Congress in Cairns, Australia (1999) we are once again travelling down under.

Let's Meet the 2018 Brisbane Congress Organisers